Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Melatonin for Pediatric Dengue Fever
NCT05034809Phase 2Unknown
- Sponsor
- Ilocos Training and Regional Medical Center
- Start
- Oct 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of melatonin in dengue fever (2 arms), sponsored by Ilocos Training and Regional Medical Center. Primary endpoint: Number Of Days Prior To Elevation of Platelet Count at 1 year. Status: unknown.
02
Drugs
melatonin
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT05034809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05034809.